BiomX Inc. (PHGE)

NYSE: PHGE · Biological Products, (No Diagnostic Substances) · Dover, DE · filing with the SEC since 2018

Full chart Alerts Compare

Grade5.2

◀ Past 4.2● Present 5.0▶ Future 6.0

8 est.

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Who owns BiomX Inc.

As filed with the SEC

Holders of 5% or more

Pyu Pyu Capital, LLC holds 20% of Common stock, $0.0001 par value, as its SCHEDULE 13D filed Jan 26, 2026 says.

Directors and officers

report now, of 42 people on the record since 2018. Their holdings as a group are not read here.

Institutions as a whole

n/a

The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.

Holders of 5% or moreshare of the class, as filed

Pyu Pyu Capital, LLC

SCHEDULE 13D · filed Jan 26, 2026 · Common stock, $0.0001 par value

20%

Mandragola Ltd.

SCHEDULE 13G · filed Oct 5, 2026 · Common Stock, par value $0.0001

9.99%

Nantahala Capital Management, LLC

SCHEDULE 13G/A · filed Aug 14, 2026 · Common stock, $0.0001 par value · 9.99% in Feb 13, 2026

7.13%

Ram Naim

SCHEDULE 13D/A · filed Oct 6, 2026 · Common Stock, par value $0.0001 per share · 4.86% in Sep 17, 2026

5.3%

Deerfield Management Company, L.P.

SCHEDULE 13D/A · filed Jun 16, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 8.09% in May 28, 2026

under 5%

T3 Defense Inc.

SCHEDULE 13D/A · filed Sep 15, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 20.4% in Apr 14, 2026

under 5%

Alyeska Investment Group, L.P.

SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, $0.0001 par value · reported falling below 5%, from 9.27% in May 15, 2025

under 5%

Cystic Fibrosis Foundation

SCHEDULE 13G/A · filed Aug 20, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 9.99% in Mar 4, 2025

under 5%

Orbimed Israel Gp Ltd.

SCHEDULE 13D/A · filed Jun 23, 2025 · Common stock, par value $0.0001 per share · reported falling below 5%

under 5%

Rodney Hodges

SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, par value $0.0001 per share · reported falling below 5%, from 5.2% in May 14, 2026

under 5%

Orin Hirschman

SCHEDULE 13G/A · filed Jan 29, 2026 · Common Stock, $0.0001 Par Value Per Share · reported falling below 5%, from 6.3% in May 8, 2025

under 5%

Morgan Stanley

SCHEDULE 13G/A · filed Aug 7, 2025 · Common Stock · reported falling below 5%, from 7.1% in Aug 5, 2025

under 5%

What PHGE reports owning in othersstakes of 5% or more, and other ties

1 subsidiary in 1 country, from the list filed with the 10-K filed Feb 19, 2026.

Insider tradesForm 4

4sales

0purchases

0sales on a scheduled plan

1people selling

$8.3Msold, in dollars

$0bought, in dollars

Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.

By calendar yearSoldBought

19212326

2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.

People who traded in the window1 of 52 on the roster

Person	Role as filed	Sales	Sold	On a plan	Buys	Bought
Yeganeh Reuven	director	4	$8.3M	0	0	$0

SI Assistanton PHGE · research, not advice